Cameroon rolls out world’s first malaria vaccine
The World Health Organization (WHO)-approved RTS,S vaccine, developed by British drugmaker GSK, is targeting infants in Cameroon's 42 worst-affected districts.
Cameroon is rolling out the world’s first routine vaccine programme against malaria, in a global fight projected to save thousands of children’s lives across Africa.
The World Health Organization (WHO)-approved RTS,S vaccine, developed by British drugmaker GSK, is targeting infants in Cameroon’s 42 worst-affected districts.
The central African country will be the first country to administer doses through a routine immunisation programme, following successful pilot campaigns in Kenya, Ghana and Malawi.
The rollout, due to start on Monday, was described by health officials as a milestone in the decades-long effort to curb malaria in the continent.
Twenty other countries aim to roll out the programme this year, according to global vaccine alliance Gavi.
The four-dose vaccine is only about 30% effective and protection begins to fade after several months.
GSK said it can only produce about 15 million doses a year.
Asaase Radio 99.5 broadcasts on radio via 99.5 in Accra, 98.5 in Kumasi, 99.7 in Tamale, 100.3 in Cape Coast and on our affiliates Bawku FM 101.5 in Bawku, Beats FM 99.9 in Bimbilla, Somua FM 89.9 in Gushegu, Stone City 90.7 in Ho, Mining City 89.5 in Tarkwa and Wale FM 106.9 in Walewale, Azay Fm 89.1 in Takoradi
Tune in to broadcasts online: asaaseradio.com, Sound Garden and TuneIn
Follow us on Twitter: @asaaseradio995
Live streaming on facebook.com/asaase99.5. Also on YouTube: AsaaseXtra.
Join the conversation. Call: 020 000 9951 or 059 415 7777. Or WhatsApp: 020 000 0995.
#Asaase321
#TheVoiceofOurLand
#WeAreHere
#WeLoveOurLand
#SafeMotorway4All
